SCHEMBL1753473

SCHEMBL1753473

Cc1ccn(-c2ccc(Br)cc2)c(=O)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.41
ALOX15 P16050 1/20 0.41
HTT P42858 1/20 0.41
ATM Q13315 1/20 0.41
POLB P06746 2/20 0.40
HSD17B10 Q99714 2/20 0.40
HPGD P15428 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
FAAH O00519 1/20 0.39
MGLL Q99685 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
KAT2B Q92831 1/20 0.39
KDM4E B2RXH2 3/20 0.38
NPC1 O15118 3/20 0.38
RAB9A P51151 3/20 0.38
F2 P00734 1/20 0.38
ELANE P08246 1/20 0.38
CTSG P08311 1/20 0.38
CMA1 P23946 1/20 0.38
CTRC Q99895 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL890168 0.86 F2 (0.52) ALDH1A1ALOX15HTTATMHSD17B10
SCHEMBL1753746 0.82 HTT (0.44) ALDH1A1ALOX15HTTATMPOLB
SCHEMBL2498016 0.81 MCHR1 (0.43) ALDH1A1ALOX15HTTATMPOLB
SCHEMBL18011087 0.81 ALDH1A1 (0.53) ALDH1A1ALOX15HTTATMHSD17B10
SCHEMBL31333305 0.80 ALDH1A1 (0.48) ALDH1A1MGLLSMN1; SMN2ALKBH5GSK3A
SCHEMBL7861231 0.80 SMN1; SMN2 (0.60) ALDH1A1HSD17B10HPGDSMN1; SMN2KDM4E
SCHEMBL12153690 0.78 ALDH1A1 (0.50) ALDH1A1HTTATMPOLBHPGD
SCHEMBL10140954 0.78 LMNA (0.47) ALDH1A1ALOX15HTTATMPOLB
SCHEMBL29348799 0.77 ALDH1A1 (0.41) ALDH1A1ALOX15HTTATMFAAH
SCHEMBL10087069 0.77 HTT (0.53) ALDH1A1ALOX15HTTATMPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8158643-B2 Substituted diaza-spiro-pyridinone derivatives for use in MCH-1 mediated diseases JANSSEN PHARMACEUTICA N.V. (BE) 2012-04-17 US disclosed
US-20100035909-A1 NOVEL SUBSTITUTED DIAZA-SPIRO-PYRIDINONE DERIVATIVES FOR USE IN MCH-1 MEDIATED DISEASES JANSSEN PHARMACEUTICA N.V. (BE) 2010-02-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100035909-A1 NOVEL SUBSTITUTED DIAZA-SPIRO-PYRIDINONE DERIVATIVES FOR USE IN MCH-1 MEDIATED DISEASES MCHR1, MCHR2, MC1R ALDH1A1 281/4885ALOX15 1811/4885HTT 636/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.